Axon Enterprise Inc. (AXON): Price and Financial Metrics

Axon Enterprise Inc. (AXON): $95.64

0.64 (+0.67%)

POWR Rating

Component Grades














  • AXON scores best on the Sentiment dimension, with a Sentiment rank ahead of 96.55% of US stocks.
  • AXON's strongest trending metric is Value; it's been moving up over the last 179 days.
  • AXON's current lowest rank is in the Value metric (where it is better than 18.12% of US stocks).

AXON Stock Summary

  • The price/operating cash flow metric for Axon Enterprise Inc is higher than 93.72% of stocks in our set with a positive cash flow.
  • For AXON, its debt to operating expenses ratio is greater than that reported by merely 0.5% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, Axon Enterprise Inc is reporting a growth rate of 2,147.26%; that's higher than 98.87% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Axon Enterprise Inc are VUZI, VLDR, LGVN, PLTR, and TTD.
  • Visit AXON's SEC page to see the company's official filings. To visit the company's web site, go to

AXON Valuation Summary

  • AXON's price/earnings ratio is -173.5; this is 766.03% lower than that of the median Industrials stock.
  • Over the past 243 months, AXON's price/sales ratio has gone up 8.8.
  • AXON's price/earnings ratio has moved down 106.8 over the prior 243 months.

Below are key valuation metrics over time for AXON.

Stock Date P/S P/B P/E EV/EBIT
AXON 2021-08-26 15.1 11.1 -173.5 -124.0
AXON 2021-08-25 15.2 11.2 -174.7 -124.9
AXON 2021-08-24 15.1 11.1 -174.1 -124.5
AXON 2021-08-23 15.2 11.2 -175.0 -125.1
AXON 2021-08-20 15.2 11.2 -175.1 -125.2
AXON 2021-08-19 14.8 10.9 -170.1 -121.5

AXON Growth Metrics

    Its 4 year net income to common stockholders growth rate is now at -109.04%.
  • The 5 year price growth rate now stands at 343.74%.
  • Its 3 year net cashflow from operations growth rate is now at -21.41%.
Over the past 15 months, AXON's revenue has gone up $236,667,000.

The table below shows AXON's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 863.381 124.494 -60.018
2021-09-30 871.943 145.882 -20.676
2021-06-30 806.396 140.573 -70.073
2021-03-31 728.86 86.005 -53.715
2020-12-31 681.003 38.481 -1.724
2020-09-30 626.714 49.972 -39.937

AXON's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AXON has a Quality Grade of B, ranking ahead of 84.9% of graded US stocks.
  • AXON's asset turnover comes in at 0.577 -- ranking 8th of 12 Defense stocks.
  • LMT, KTOS, and VSTO are the stocks whose asset turnover ratios are most correlated with AXON.

The table below shows AXON's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.577 0.621 -0.104
2021-03-31 0.550 0.619 -0.067
2020-12-31 0.571 0.611 -0.009
2020-09-30 0.592 0.587 -0.046
2020-06-30 0.631 0.591 -0.032
2020-03-31 0.689 0.582 -0.007

AXON Price Target

For more insight on analysts targets of AXON, see our AXON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $213.00 Average Broker Recommendation 1.41 (Moderate Buy)

AXON Stock Price Chart Interactive Chart >

Price chart for AXON

AXON Price/Volume Stats

Current price $95.64 52-week high $209.00
Prev. close $95.00 52-week low $82.49
Day low $92.25 Volume 333,000
Day high $96.22 Avg. volume 470,187
50-day MA $100.63 Dividend yield N/A
200-day MA $140.02 Market Cap 6.79B

Axon Enterprise Inc. (AXON) Company Bio

Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and impaired daily function. The company was founded in 2014 and is based in Hamilton, Bermuda.

AXON Latest News Stream

Event/Time News Detail
Loading, please wait...

AXON Latest Social Stream

Loading social stream, please wait...

View Full AXON Social Stream

Latest AXON News From Around the Web

Below are the latest news stories about Axon Enterprise Inc that investors may wish to consider to help them evaluate AXON as an investment opportunity.

Top Defense Stocks for Q1 2022

The defense industry produces modern weaponry, including combat vehicles, ships, bombers, and fighter jets. Companies in the industry also offer cybersecurity, information technology (IT), analytics, robotics, and intelligence systems. Its primary customer is the U.S. government, but it also sells its products and services to foreign governments and law enforcement agencies.

Yahoo | February 25, 2022

3 Top Defense Stocks to Buy Right Now on Ukraine Invasion News

Global tensions are rising after Russia invaded Ukraine.

Samuel O'Brient on InvestorPlace | February 24, 2022

Axon Enterprise (AXON) Q4 Earnings and Revenues Surpass Estimates

Axon (AXON) delivered earnings and revenue surprises of 187.50% and 7.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Axon Reports 2021 Results: Third Straight Year of 25%+ Revenue Growth

Axon Reports 2021 Results: Third Straight Year of 25%+ Revenue Growth

Yahoo | February 24, 2022

Cathie Wood’s Latest Portfolio: 10 New Stock Picks

In this article, we discuss the 10 new stocks that Cathie Wood added to her portfolio in Q4 2021. You can skip our comprehensive analysis of ARK Investment Management’s investment strategy, and go directly to Cathie Wood’s Latest Portfolio: 5 New Stock Picks. Cathie Wood is the CEO, CIO, and founder of ARK Investment Management. Starting […]

Yahoo | February 18, 2022

Read More 'AXON' Stories Here

AXON Price Returns

1-mo -5.64%
3-mo -31.35%
6-mo -39.08%
1-year -45.90%
3-year N/A
5-year N/A
YTD -39.08%
2021 28.13%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.3961 seconds.